PFMD published its inaugural paper, entitled Culture and process change as a priority for patient engagement in medicines development, in the peer-reviewed journal, Therapeutic Innovation & Regulatory Science (TIRS).
With Marc Boutin, Chief Executive Officer of the US National Health Council and PFMD founding member as lead author, the article argues that a global environment that embraces and facilitates patient engagement is essential to medicine development and better patient outcomes, but is only attainable if we remove barriers and promote effective implementation.
Read the paper
Photo credits: Gothic san serif lower case – FUTURA!, by Kyle Van Horn, used under the Creative Commons license
Inaugural publication calls for culture and process change to ‘embrace and facilitate’ patient engagement
Tags:
